Paris, Ile-de-France, France The venture was found in Europe in France. The main department of described VC is located in the Paris.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the NAXOS Capital Partners, startups are often financed by Unilever Ventures, Swarraton Partners, Mitsui Global Investment. The meaningful sponsors for the fund in investment in the same round are Swarraton Partners, Unilever Ventures, University of Oxford. In the next rounds fund is usually obtained by Clydesdale Bank, Yorkshire Bank, Unilever Ventures.
The fund was created by Carole Piwnica. The overall number of key employees were 2.
The fund has no specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as CleanTech, Energy. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight P2i, BioAmber.
This NAXOS Capital Partners works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2010. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 23 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2013.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Archer Venture Capital | California, Los Angeles, United States |
| Broadcom | California, San Jose, United States |
| Grand Industrial | China, Jiangsu, Lianyungang |
| jVen Capital | Maryland, Potomac, United States |
| marquee angels | - |
| NTT Communications | Japan, Tokyo |
| Velux Foundation | Denmark, Hovedstaden, Søborg |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioAmber | $30M | 22 Feb 2012 | Minnesota, United States | ||
BioAmber | $45M | 04 May 2011 | Minnesota, United States | ||
Elevance Renewable Sciences | $100M | 21 Dec 2010 | Illinois, United States | ||
| $5M | 07 Jun 2010 | East Suffolk, England, United Kingdom | |||
P2i | $5M | 20 Jul 2009 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioAmber | $30M | 22 Feb 2012 | Minnesota, United States | ||
BioAmber | $45M | 04 May 2011 | Minnesota, United States | ||
Elevance Renewable Sciences | $100M | 21 Dec 2010 | Illinois, United States | ||
| $5M | 07 Jun 2010 | East Suffolk, England, United Kingdom | |||
P2i | $5M | 20 Jul 2009 | United Kingdom, England |
